Abstract
Infectious endophthalmitis is a growing concern that causes irreversible intraocular tissue and optic nerve damage. Here, we report a theranostic nanoplatform based on UiO-66-NH2 to combine photodynamic therapy (PDT) and lipopolysaccharide (LPS) targeting through polypeptide (YVLWKRKRKFCFI-NH2) modification. Toluidine blue (TB), serving as a photosensitizer (PS), is loaded into UiO-66-NH2 nanoparticles (NPs) for both self-imaging and PDT functions. The accelerated TB release at pH 5.5 compared to pH 7.4 demonstrates the responsive drug release feature. In vitro antibacterial tests, including contact incubation-agar plate counting, bacterial live/dead staining, and scanning electron microscopy observations, confirm the utility of the [email protected]2@PEP&PEG NPs (UTPP NPs) in biofilms removal and sterilization of Pseudomonas aeruginosa and Staphylococcus epidermidis. Furthermore, the UTPP NPs also show good biocompatibility toward human retinal pigment epithelial cells, as well as in situ self-imaging property. Finally, an in vivo infectious endophthalmitis model supports the application of the UTPP NPs in infectious endophthalmitis treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
